Natriumhydrogencarbonat B. Braun (Sodium Hydrogen Carbonate)

Sodium hydrogen carbonate, the active ingredient in Natriumhydrogencarbonat B. Braun, is an electrolyte/alkalinizing agent presented as an injectable solution for intravenous use. It provides bicarbonate ions to buffer excess hydrogen ions, thereby raising systemic pH and correcting metabolic acidosis in acute care settings.

GNH USA supplies Natriumhydrogencarbonat B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product is manufactured in the European Union under stringent quality standards and is distributed through GNH USA's global network.

Natriumhydrogencarbonat B. Braun is used to manage disorders of acid‑base balance by supplying bicarbonate.

- Metabolic acidosis: raises blood pH and restores normal acid‑base status. - Hyperkalemia: promotes intracellular shift of potassium, helping lower serum potassium levels. - General acid‑base disorders: provides systemic buffering to correct pH abnormalities. - Urinary alkalinization: increases urinary pH to facilitate excretion of certain toxins or drugs.

Adverse reactions may occur with intravenous sodium hydrogen carbonate administration.

Common Side Effects: - Hypernatremia: elevated serum sodium levels. - Metabolic alkalosis: excessive rise in blood pH. - Fluid overload: volume expansion leading to edema. - Hypokalemia: reduced serum potassium. - Infusion site irritation: pain or erythema at the injection site.

Serious or Rare Side Effects: - Severe metabolic alkalosis: can cause respiratory depression. - Pulmonary edema: accumulation of fluid in the lungs. - Anaphylactic reaction: rare but potentially life‑threatening hypersensitivity. - Severe hypernatremia: may result in neurological symptoms. - Thrombophlebitis: inflammation of a vein with clot formation.

Prior assessment and monitoring are essential when using intravenous sodium hydrogen carbonate. - Assess acid‑base status before administration: confirm presence of metabolic acidosis. - Monitor serum electrolytes: watch for hypernatremia, hypokalemia, and alkalosis. - Adjust dose in renal impairment: reduced clearance may increase bicarbonate accumulation. - Infuse at recommended rate: avoid rapid administration that could precipitate alkalosis. - Use with caution in heart failure: risk of fluid overload. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium hydrogen carbonate can interact with several agents; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Concurrent use of other alkalinizing agents (e.g., oral sodium bicarbonate): risk of severe metabolic alkalosis. - Co‑administration with hypertonic saline solutions: may cause marked hypernatremia. - Simultaneous infusion of calcium‑containing solutions: potential precipitation. - Use with mineral acids (e.g., ammonium chloride): antagonizes bicarbonate effect.

Moderate Interactions (Monitor Closely): - Concomitant loop diuretics: may exacerbate electrolyte shifts. - ACE inhibitors or ARBs: monitor potassium levels closely. - Certain antibiotics (e.g., aminoglycosides): renal clearance may be altered. - Insulin therapy: monitor glucose as bicarbonate can affect insulin sensitivity.